MedPath

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic Cancer

Phase 2
Completed
Conditions
Pancreatic Cancer
Registration Number
NCT00025168
Lead Sponsor
Wake Forest University Health Sciences
Brief Summary

RATIONALE: Drugs used in chemotherapy, such as gemcitabine and irinotecan, work in different ways to stop tumor cells from dividing so they stop growing or die. Combining radiation therapy with chemotherapy may kill more tumor cells.

PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy and radiation therapy in treating patients who have locally advanced, unresectable pancreatic cancer.

Detailed Description

OBJECTIVES:

* Determine the time to progression, local control, and survival of patients with locally advanced, unresectable pancreatic cancer treated with induction gemcitabine and irinotecan followed by gemcitabine and concurrent radiotherapy.

OUTLINE: Patients receive induction gemcitabine IV over 30 minutes and irinotecan IV over 90 minutes on days 1 and 8. Treatment repeats every 3 weeks for 2 courses in the absence of disease progression or unacceptable toxicity.

Within 2 weeks of completing induction chemotherapy, patients receive gemcitabine IV over 30-60 minutes on days 1, 4, 8, 11, 15, 18, 22, 25, 29, and 32. Patients undergo concurrent radiotherapy 5 days a week for 5.5 weeks.

Patients are followed every 8 weeks for 6 months and then every 3 months for 1.5 years.

PROJECTED ACCRUAL: Approximately 60-120 patients will be accrued for this study within 1-2 years.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (7)

Lineberger Comprehensive Cancer Center, UNC

πŸ‡ΊπŸ‡Έ

Chapel Hill, North Carolina, United States

Southeastern Medical Oncology Center

πŸ‡ΊπŸ‡Έ

Goldsboro, North Carolina, United States

East Carolina University School of Medicine

πŸ‡ΊπŸ‡Έ

Greenville, North Carolina, United States

Comprehensive Cancer Center at Wake Forest University

πŸ‡ΊπŸ‡Έ

Winston-Salem, North Carolina, United States

Hollings Cancer Center at Medical University of South Carolina

πŸ‡ΊπŸ‡Έ

Charleston, South Carolina, United States

Greenville Hospital System

πŸ‡ΊπŸ‡Έ

Greenville, South Carolina, United States

Spartanburg Regional Healthcare System

πŸ‡ΊπŸ‡Έ

Spartanburg, South Carolina, United States

Lineberger Comprehensive Cancer Center, UNC
πŸ‡ΊπŸ‡ΈChapel Hill, North Carolina, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.